Insights into natriuretic peptides in heart failure: An update View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06

AUTHORS

Josef Korinek, Guido Boerrigter, Selma F. Mohammed, John C. Burnett

ABSTRACT

Natriuretic peptides (NPs) secreted by the heart in response to volume overload are pleiotropic molecules with vasodilating, diuretic, natriuretic, antiproliferative, and antifibrotic actions. Functioning of the NP system is altered in congestive heart failure (CHF), suggesting that support of the NP system might be beneficial in treatment of acute and chronic CHF. Several approaches alone or in combination with other pharmacologic therapies have been shown to enhance function of the NP system: direct administration of native and designer NPs, inhibition of degradation of NPs and their second messenger (cyclic guanosine monophosphate [cGMP]), and stimulation of cGMP generation. Despite increasing numbers of studies using NPs in therapy of acute and chronic CHF, several controversies regarding safety, efficacy, and dosing of NPs need to be addressed. Moreover, further research is warranted to identify the stages and etiologies of CHF that may profit from NP therapy. More... »

PAGES

97-104

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11897-008-0016-y

DOI

http://dx.doi.org/10.1007/s11897-008-0016-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038509334

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18765080


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclic GMP", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptide, Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptide, C-Type", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renin-Angiotensin System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Korinek", 
        "givenName": "Josef", 
        "id": "sg:person.0753213563.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753213563.81"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Boerrigter", 
        "givenName": "Guido", 
        "id": "sg:person.01021616027.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021616027.74"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Mohammed", 
        "givenName": "Selma F.", 
        "id": "sg:person.0646060617.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646060617.69"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Burnett", 
        "givenName": "John C.", 
        "id": "sg:person.01001266776.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/b:pham.0000048203.30568.81", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004340827", 
          "https://doi.org/10.1023/b:pham.0000048203.30568.81"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051687311", 
          "https://doi.org/10.1038/nrd2399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11095-007-9286-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019200894", 
          "https://doi.org/10.1007/s11095-007-9286-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1199", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015601292", 
          "https://doi.org/10.1038/nbt1199"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06", 
    "datePublishedReg": "2008-06-01", 
    "description": "Natriuretic peptides (NPs) secreted by the heart in response to volume overload are pleiotropic molecules with vasodilating, diuretic, natriuretic, antiproliferative, and antifibrotic actions. Functioning of the NP system is altered in congestive heart failure (CHF), suggesting that support of the NP system might be beneficial in treatment of acute and chronic CHF. Several approaches alone or in combination with other pharmacologic therapies have been shown to enhance function of the NP system: direct administration of native and designer NPs, inhibition of degradation of NPs and their second messenger (cyclic guanosine monophosphate [cGMP]), and stimulation of cGMP generation. Despite increasing numbers of studies using NPs in therapy of acute and chronic CHF, several controversies regarding safety, efficacy, and dosing of NPs need to be addressed. Moreover, further research is warranted to identify the stages and etiologies of CHF that may profit from NP therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11897-008-0016-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2437014", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2384951", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2540817", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2532198", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1033049", 
        "issn": [
          "1546-9530", 
          "1546-9549"
        ], 
        "name": "Current Heart Failure Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "congestive heart failure", 
      "chronic congestive heart failure", 
      "natriuretic peptide", 
      "heart failure", 
      "etiology of CHF", 
      "designer natriuretic peptide", 
      "pharmacologic therapy", 
      "volume overload", 
      "antifibrotic action", 
      "cGMP generation", 
      "NP therapy", 
      "pleiotropic molecule", 
      "direct administration", 
      "inhibition of degradation", 
      "therapy", 
      "number of studies", 
      "second messenger", 
      "further research", 
      "vasodilating", 
      "NP system", 
      "failure", 
      "dosing", 
      "etiology", 
      "peptides", 
      "administration", 
      "efficacy", 
      "stimulation", 
      "treatment", 
      "heart", 
      "inhibition", 
      "overload", 
      "safety", 
      "response", 
      "messenger", 
      "controversy", 
      "study", 
      "action", 
      "update", 
      "stage", 
      "combination", 
      "function", 
      "support", 
      "number", 
      "molecules", 
      "system", 
      "research", 
      "insights", 
      "approach", 
      "generation", 
      "degradation", 
      "dosing of NPs"
    ], 
    "name": "Insights into natriuretic peptides in heart failure: An update", 
    "pagination": "97-104", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038509334"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11897-008-0016-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18765080"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11897-008-0016-y", 
      "https://app.dimensions.ai/details/publication/pub.1038509334"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_461.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11897-008-0016-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11897-008-0016-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11897-008-0016-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11897-008-0016-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11897-008-0016-y'


 

This table displays all metadata directly associated to this object as RDF triples.

235 TRIPLES      22 PREDICATES      102 URIs      90 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11897-008-0016-y schema:about N34064eeb96434da2826b08ff4e47b146
2 N4eddb2f70bef484aa8177b507108d6ed
3 N59b4719b33ca4930b43e97a5fdab1008
4 N62f1f63b656944c8a0d3d7e1e55993e5
5 N66f03cd22b5f43c3ac89519a8e5bb5bc
6 N7e899eba0c634bebb5f4e3c8c13ebd99
7 N8811d88ef9be44ce91666ae665453eef
8 N8e454007f7194db596dddb57e29da3bc
9 N90979ea8e9cc4d4fa65232a8b726bba9
10 N9595946d8fd1481995eb7b892dd23b06
11 N95d7f6effa4347adabdd6b2ec9f24122
12 Nb3e53cce57cd446e8c09e81170f075a4
13 Nb5adf340763442f781cd3d9522d958a5
14 Nbebbabc226724da7a600ddce9c7aebe3
15 Nc0e1cfa7308a4489aa655eb9dcb9e4b6
16 Nddc5c5ddbd4b41ec801ccba52a43d222
17 Ne129793e3dc949978ce82add4676dc18
18 Ne3923af70b4d49198c1bc61e0a121201
19 Nf20ddbcc19364d9282c538df7aa9666d
20 Nf8f8ab20cf824ea59577e9e8093d0f68
21 anzsrc-for:11
22 anzsrc-for:1102
23 schema:author N20a78c6e849a449c8ac789673cf8321b
24 schema:citation sg:pub.10.1007/s11095-007-9286-4
25 sg:pub.10.1023/b:pham.0000048203.30568.81
26 sg:pub.10.1038/nbt1199
27 sg:pub.10.1038/nrd2399
28 schema:datePublished 2008-06
29 schema:datePublishedReg 2008-06-01
30 schema:description Natriuretic peptides (NPs) secreted by the heart in response to volume overload are pleiotropic molecules with vasodilating, diuretic, natriuretic, antiproliferative, and antifibrotic actions. Functioning of the NP system is altered in congestive heart failure (CHF), suggesting that support of the NP system might be beneficial in treatment of acute and chronic CHF. Several approaches alone or in combination with other pharmacologic therapies have been shown to enhance function of the NP system: direct administration of native and designer NPs, inhibition of degradation of NPs and their second messenger (cyclic guanosine monophosphate [cGMP]), and stimulation of cGMP generation. Despite increasing numbers of studies using NPs in therapy of acute and chronic CHF, several controversies regarding safety, efficacy, and dosing of NPs need to be addressed. Moreover, further research is warranted to identify the stages and etiologies of CHF that may profit from NP therapy.
31 schema:genre article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N192df3ae357f4d0cb22f296dcbc4ede1
35 N4e08627819a2437eafd6d8e7fcec6a35
36 sg:journal.1033049
37 schema:keywords NP system
38 NP therapy
39 action
40 administration
41 antifibrotic action
42 approach
43 cGMP generation
44 chronic congestive heart failure
45 combination
46 congestive heart failure
47 controversy
48 degradation
49 designer natriuretic peptide
50 direct administration
51 dosing
52 dosing of NPs
53 efficacy
54 etiology
55 etiology of CHF
56 failure
57 function
58 further research
59 generation
60 heart
61 heart failure
62 inhibition
63 inhibition of degradation
64 insights
65 messenger
66 molecules
67 natriuretic peptide
68 number
69 number of studies
70 overload
71 peptides
72 pharmacologic therapy
73 pleiotropic molecule
74 research
75 response
76 safety
77 second messenger
78 stage
79 stimulation
80 study
81 support
82 system
83 therapy
84 treatment
85 update
86 vasodilating
87 volume overload
88 schema:name Insights into natriuretic peptides in heart failure: An update
89 schema:pagination 97-104
90 schema:productId N11af48f61fc94d16b5f18e7a6912ef95
91 N29f97ed0cb6b4e0f8e28a3bb44ef5177
92 N89e134134f634a93a15e802259989d7e
93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038509334
94 https://doi.org/10.1007/s11897-008-0016-y
95 schema:sdDatePublished 2022-01-01T18:18
96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
97 schema:sdPublisher N9b53bd595d50487a9f6bb742fbfa1e94
98 schema:url https://doi.org/10.1007/s11897-008-0016-y
99 sgo:license sg:explorer/license/
100 sgo:sdDataset articles
101 rdf:type schema:ScholarlyArticle
102 N11af48f61fc94d16b5f18e7a6912ef95 schema:name doi
103 schema:value 10.1007/s11897-008-0016-y
104 rdf:type schema:PropertyValue
105 N192df3ae357f4d0cb22f296dcbc4ede1 schema:volumeNumber 5
106 rdf:type schema:PublicationVolume
107 N20a78c6e849a449c8ac789673cf8321b rdf:first sg:person.0753213563.81
108 rdf:rest N7ed6756db6734604862c8756f36e3f01
109 N29f97ed0cb6b4e0f8e28a3bb44ef5177 schema:name dimensions_id
110 schema:value pub.1038509334
111 rdf:type schema:PropertyValue
112 N34064eeb96434da2826b08ff4e47b146 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Drug Administration Schedule
114 rdf:type schema:DefinedTerm
115 N398c178d8c294e928507b081fe3d2527 rdf:first sg:person.0646060617.69
116 rdf:rest Nf50c40d1ea4a4773897f9a95278cc76b
117 N4e08627819a2437eafd6d8e7fcec6a35 schema:issueNumber 2
118 rdf:type schema:PublicationIssue
119 N4eddb2f70bef484aa8177b507108d6ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cyclic GMP
121 rdf:type schema:DefinedTerm
122 N59b4719b33ca4930b43e97a5fdab1008 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Renin-Angiotensin System
124 rdf:type schema:DefinedTerm
125 N62f1f63b656944c8a0d3d7e1e55993e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 N66f03cd22b5f43c3ac89519a8e5bb5bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Treatment Outcome
130 rdf:type schema:DefinedTerm
131 N7e899eba0c634bebb5f4e3c8c13ebd99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Drug Therapy, Combination
133 rdf:type schema:DefinedTerm
134 N7ed6756db6734604862c8756f36e3f01 rdf:first sg:person.01021616027.74
135 rdf:rest N398c178d8c294e928507b081fe3d2527
136 N8811d88ef9be44ce91666ae665453eef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Natriuretic Peptide, Brain
138 rdf:type schema:DefinedTerm
139 N89e134134f634a93a15e802259989d7e schema:name pubmed_id
140 schema:value 18765080
141 rdf:type schema:PropertyValue
142 N8e454007f7194db596dddb57e29da3bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Chronic Disease
144 rdf:type schema:DefinedTerm
145 N90979ea8e9cc4d4fa65232a8b726bba9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Dose-Response Relationship, Drug
147 rdf:type schema:DefinedTerm
148 N9595946d8fd1481995eb7b892dd23b06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Randomized Controlled Trials as Topic
150 rdf:type schema:DefinedTerm
151 N95d7f6effa4347adabdd6b2ec9f24122 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Severity of Illness Index
153 rdf:type schema:DefinedTerm
154 N9b53bd595d50487a9f6bb742fbfa1e94 schema:name Springer Nature - SN SciGraph project
155 rdf:type schema:Organization
156 Nb3e53cce57cd446e8c09e81170f075a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Female
158 rdf:type schema:DefinedTerm
159 Nb5adf340763442f781cd3d9522d958a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Prognosis
161 rdf:type schema:DefinedTerm
162 Nbebbabc226724da7a600ddce9c7aebe3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Natriuretic Peptides
164 rdf:type schema:DefinedTerm
165 Nc0e1cfa7308a4489aa655eb9dcb9e4b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Male
167 rdf:type schema:DefinedTerm
168 Nddc5c5ddbd4b41ec801ccba52a43d222 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Risk Assessment
170 rdf:type schema:DefinedTerm
171 Ne129793e3dc949978ce82add4676dc18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Sensitivity and Specificity
173 rdf:type schema:DefinedTerm
174 Ne3923af70b4d49198c1bc61e0a121201 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Heart Failure
176 rdf:type schema:DefinedTerm
177 Nf20ddbcc19364d9282c538df7aa9666d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Natriuretic Peptide, C-Type
179 rdf:type schema:DefinedTerm
180 Nf50c40d1ea4a4773897f9a95278cc76b rdf:first sg:person.01001266776.01
181 rdf:rest rdf:nil
182 Nf8f8ab20cf824ea59577e9e8093d0f68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Acute Disease
184 rdf:type schema:DefinedTerm
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
189 schema:name Cardiorespiratory Medicine and Haematology
190 rdf:type schema:DefinedTerm
191 sg:grant.2384951 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-008-0016-y
192 rdf:type schema:MonetaryGrant
193 sg:grant.2437014 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-008-0016-y
194 rdf:type schema:MonetaryGrant
195 sg:grant.2532198 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-008-0016-y
196 rdf:type schema:MonetaryGrant
197 sg:grant.2540817 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-008-0016-y
198 rdf:type schema:MonetaryGrant
199 sg:journal.1033049 schema:issn 1546-9530
200 1546-9549
201 schema:name Current Heart Failure Reports
202 schema:publisher Springer Nature
203 rdf:type schema:Periodical
204 sg:person.01001266776.01 schema:familyName Burnett
205 schema:givenName John C.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01
207 rdf:type schema:Person
208 sg:person.01021616027.74 schema:familyName Boerrigter
209 schema:givenName Guido
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021616027.74
211 rdf:type schema:Person
212 sg:person.0646060617.69 schema:familyName Mohammed
213 schema:givenName Selma F.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646060617.69
215 rdf:type schema:Person
216 sg:person.0753213563.81 schema:affiliation grid-institutes:grid.66875.3a
217 schema:familyName Korinek
218 schema:givenName Josef
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753213563.81
220 rdf:type schema:Person
221 sg:pub.10.1007/s11095-007-9286-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019200894
222 https://doi.org/10.1007/s11095-007-9286-4
223 rdf:type schema:CreativeWork
224 sg:pub.10.1023/b:pham.0000048203.30568.81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004340827
225 https://doi.org/10.1023/b:pham.0000048203.30568.81
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/nbt1199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015601292
228 https://doi.org/10.1038/nbt1199
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/nrd2399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051687311
231 https://doi.org/10.1038/nrd2399
232 rdf:type schema:CreativeWork
233 grid-institutes:grid.66875.3a schema:alternateName Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA
234 schema:name Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA
235 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...